The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 trial evaluating intratumoral administration of INT230-6 alone and in combination with an anti-PD1 antibody for advanced malignancies.
 
Yada Kanjanapan
No Relationships to Disclose
 
Nilofer Saba Azad
Honoraria - AMAG Pharmaceuticals; Bayer/Onyx
Consulting or Advisory Role - AMAG Pharmaceuticals; Dava Oncology
Research Funding - Agios (Inst); Array BioPharma (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Intensity Therapeutics; Merck (Inst); Syndax (Inst)
 
Lillian L. Siu
Leadership - Agios (I)
Consulting or Advisory Role - AstraZeneca/MedImmune; Merck; MorphoSys; Symphony Evolution
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Symphony Evolution (Inst)
 
Anthony J. Olszanski
Consulting or Advisory Role - Bristol-Myers Squibb; G1 Therapeutics; Merck; Takeda
Research Funding - Advaxis (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ignyta (Inst); Immunocore (Inst); Incyte (Inst); Kura Oncology (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Takeda
 
Ian B Walters
Employment - Intensity Therapeutics; Samsung Bioepis
Leadership - Portage Biotech
Stock and Other Ownership Interests - Intensity Therapeutics; Portage Biotech; Slate Pharmaceuticals
 
Lisa Kamen
Employment - Kolltan Pharmaceuticals
Consulting or Advisory Role - Biohaven Pharmaceuticals; Celldex; GestVision; Intensity Therapeutics; Osmol Therapeutics
 
Lewis H. Bender
Employment - Intensity Therapeutics
Stock and Other Ownership Interests - Intensity Therapeutics
 
Anthony B. El-Khoueiry
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Merck; Novartis; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Merck; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca